GRANT FOR THE STUDY OF HEMATOPOIETIC STEM CELL TRANSPLANTATION AND CELL THERAPIES IN HEMATOLOGIC MALIGNANCIES
In honor of John A. Hansen, this grant is intended to provide financial support to promising young researchers to advance the understanding of complications and therapeutic strategies in the context of hematologic malignancies. The grant is funded by the DKMS Stiftung Leben Spenden (Foundation for Giving Life) and administered by the DKMS gGmbH.
The John Hansen Research Grant awards €240,000 ($270,000) over a period of three years (maximum €80,000/$90,000 per year), subject to reasonable progress of the research. Up to four projects will be selected from among the eligible applications.
The research proposal must address issues on hematopoietic stem cell transplantation or cell therapy. Various aspects can be covered, including but not limited to: diagnostic and therapeutic strategies, transplant immunology, stem cell transplantation complications, donor selection or cell manufacturing.
DEADLINE FOR SUBMISSION 8TH DECEMBER 2020
Dr. Andrea Schmidts of the Massachusetts General Hospital Cancer Center in Charlestown
Project title: “CRISPR-based Modeling of Genetic Resistance to CAR-T Cell Therapy for Multiple Myeloma”
Dr. Yiouli Ktena of the Johns Hopkins University in Baltimore
Project title: “Defining the role and targets of T cell DNA methylation in control of graft-versus-host disease and the graft-versus-tumor effect after allogeneic hematopoietic stem cell transplantation”
Out of appreciation and gratitude the DKMS Stiftung Leben Spenden renamed its research program, with which it promotes highly talented junior scientists every year: The Mechtild Harf Research Grant is now called the John Hansen Research Grant.
Find more information here.